NanoViricides (NNVC) Says Topical Drug Candidates for Treatment of Shingles Demonstrated Excellent Inhibition of Causative Virus
Tweet Send to a Friend
NanoViricides, Inc., (NYSE: NNVC) (the "Company"), a pioneer in developing anti-viral nanomedicine drugs, reports that its topical drug candidates in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
